Characterizing the spatiotemporal displacement of fiducial markers for cyberknife radiosurgery in liver cancer and identifying predictive factors.
5 affiliations
- 1Radiotherapy Center, The First Hospital of Hebei Medical University, No. 89 Donggang Road, Shijiazhuang, Hebei, 050000, China.
- 2Department of Gastrointestinal Diseases IV (Tumor Endoscopy), The First Hospital of Hebei Medical University, No. 89 Donggang Road, Shijiazhuang, Hebei, 050000, China.
- 3Department of Oncology III (Head, Neck, Brain and Esophageal Tumors), The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
- 4Department of Gastrointestinal Diseases IV (Tumor Endoscopy), The First Hospital of Hebei Medical University, No. 89 Donggang Road, Shijiazhuang, Hebei, 050000, China. [email protected].
- 5Radiotherapy Center, The First Hospital of Hebei Medical University, No. 89 Donggang Road, Shijiazhuang, Hebei, 050000, China. [email protected].
Abstract
Purpose
Fiducial markers are essential for accurate image-guided stereotactic body radiotherapy (SBRT) in hepatocellular carcinoma (HCC). However, post-implantation positional variation introduces geometric uncertainty. This study aims to quantify the spatiotemporal observed displacement of fiducial markers in HCC patients treated with CyberKnife SBRT and to identify predictive factors for significant displacement.Methods
We retrospectively reviewed data from 185 HCC patients who underwent percutaneous implantation of 518 fiducial markers between January 2018 and December 2022. Serial CT scans were acquired at baseline (Day 1) and on days 3, 5, 7, 10, and 14 post-implantation. Fiducial displacement was measured in three dimensions (craniocaudal, anteroposterior, mediolateral) relative to the baseline scan after rigid registration to vertebral bodies. Significant displacement was defined as a 3D vector displacement > 3 mm, encompassing true migration and geometrical uncertainties. To account for data clustering (multiple markers per patient), univariate and multivariable Generalized Estimating Equations (GEE) models were used to identify predictors of significant displacement. Internal validation was performed using bootstrap resampling. Furthermore, a dosimetric analysis was conducted to evaluate the clinical impact of significant marker displacement.Results
The mean 3D vector displacement was greatest at Day 3 (2.8 ± 1.5 mm) and progressively decreased, plateauing after Day 7 (Day 7: 1.9 ± 1.1 mm; Day 14: 1.8 ± 1.0 mm; p < 0.001 for trend). The craniocaudal axis exhibited the largest magnitude of displacement. By Day 7, 88.6% of markers achieved stability (displacement ≤ 3 mm). Dosimetric evaluation revealed that simulated displacement > 3 mm significantly degraded target coverage (PTV V100%: 98.5% vs. 92.1%, p < 0.001). Multivariate GEE analysis identified tumor location within 2 cm of the diaphragm (Odds Ratio [OR] = 3.05, 95% CI: 1.75-5.20, p < 0.001) and tumor diameter > 5 cm (OR = 1.98, 95% CI: 1.15-3.30, p = 0.012) as independent predictors for significant fiducialisplacement. The optimism-corrected area under the curve (AUC) for the predictive model was 0.76.Conclusion
Fiducial markers in HCC patients undergo significant early displacement, primarily within the first week, and stabilize thereafter. Proximity to the diaphragm and larger tumor size are associated with a higher risk of displacement, which can negatively impact delivered dosimetry in simulated scenarios. These findings support a recommended 7-day waiting period between implantation and CT simulation as a reasonable safety guideline and suggest that patients with high-risk features may benefit from extended monitoring or adaptive radiotherapy strategies.
Related
- Dosimetric Comparison of Functional Radiosurgery Treatments for Trigeminal Neuralgia, Essential Tremor, and Obsessive-compulsive Disorder Using Gamma Knife, CyberKnife, and Linear Accelerators
- Charge-Selective Displacement of Spatiotemporal Optical Vortices at a Spatially Uniform Time Boundary
- GWTC-5.0: Methods for Identifying and Characterizing Gravitational-wave Transients
- Implementation and preliminary evaluation of a practical digital workflow for routine laser-radiation field coincidence quality assurance on the CyberKnife M6.
- Clinical application of MR-Only in cyberknife stereotactic radiotherapy for brain metastases: a feasibility study
BibTeX
@article{zhang2026characterizing,
title = {{Characterizing the spatiotemporal displacement of fiducial markers for cyberknife radiosurgery in liver cancer and identifying predictive factors.}},
author = {Miaomiao Zhang and Lei Nie and Dengcui Zhao and Hui Xu and Guihua Zhang and Bo Tian},
journal = {BMC cancer},
year = {2026},
month = jul,
doi = {10.1186/s12885-026-16246-1},
url = {https://europepmc.org/article/MED/42894144},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Characterizing the spatiotemporal displacement of fiducial markers for cyberknife radiosurgery in liver cancer and identifying predictive factors.
AU - Miaomiao Zhang
AU - Lei Nie
AU - Dengcui Zhao
AU - Hui Xu
AU - Guihua Zhang
AU - Bo Tian
PY - 2026
DA - 2026/07/01
JO - BMC cancer
DO - 10.1186/s12885-026-16246-1
UR - https://europepmc.org/article/MED/42894144
AB - Purpose Fiducial markers are essential for accurate image-guided stereotactic body radiotherapy (SBRT) in hepatocellular carcinoma (HCC). However, post-implantation positional variation introduces geometric uncertainty. This study aims to quantify the spatiotemporal observed displacement of fiducial markers in HCC patients treated with CyberKnife SBRT and to identify predictive factors for significant displacement.Methods We retrospectively reviewed data from 185 HCC patients who underwent percutaneous implantation of 518 fiducial markers between January 2018 and December 2022. Serial CT scans were acquired at baseline (Day 1) and on days 3, 5, 7, 10, and 14 post-implantation. Fiducial displacement was measured in three dimensions (craniocaudal, anteroposterior, mediolateral) relative to the baseline scan after rigid registration to vertebral bodies. Significant displacement was defined as a 3D vector displacement > 3 mm, encompassing true migration and geometrical uncertainties. To account for data clustering (multiple markers per patient), univariate and multivariable Generalized Estimating Equations (GEE) models were used to identify predictors of significant displacement. Internal validation was performed using bootstrap resampling. Furthermore, a dosimetric analysis was conducted to evaluate the clinical impact of significant marker displacement.Results The mean 3D vector displacement was greatest at Day 3 (2.8 ± 1.5 mm) and progressively decreased, plateauing after Day 7 (Day 7: 1.9 ± 1.1 mm; Day 14: 1.8 ± 1.0 mm; p < 0.001 for trend). The craniocaudal axis exhibited the largest magnitude of displacement. By Day 7, 88.6% of markers achieved stability (displacement ≤ 3 mm). Dosimetric evaluation revealed that simulated displacement > 3 mm significantly degraded target coverage (PTV V100%: 98.5% vs. 92.1%, p < 0.001). Multivariate GEE analysis identified tumor location within 2 cm of the diaphragm (Odds Ratio [OR] = 3.05, 95% CI: 1.75-5.20, p < 0.001) and tumor diameter > 5 cm (OR = 1.98, 95% CI: 1.15-3.30, p = 0.012) as independent predictors for significant fiducialisplacement. The optimism-corrected area under the curve (AUC) for the predictive model was 0.76.Conclusion Fiducial markers in HCC patients undergo significant early displacement, primarily within the first week, and stabilize thereafter. Proximity to the diaphragm and larger tumor size are associated with a higher risk of displacement, which can negatively impact delivered dosimetry in simulated scenarios. These findings support a recommended 7-day waiting period between implantation and CT simulation as a reasonable safety guideline and suggest that patients with high-risk features may benefit from extended monitoring or adaptive radiotherapy strategies.
SN - 1471-2407
ER -